Soft Tissue Allografts Market

Soft Tissue Allografts Market (Product Type: Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Collagen Allografts, and Amniotic Allografts) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Soft Tissue Allografts Market Outlook 2031

  • The global soft tissue allografts market was valued at US$ 3.74 Bn in 2021
  • The global market is projected to grow at a CAGR of 5.5% from 2022 to 2031
  • The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031

Analysts’ Viewpoint on Soft Tissue Allografts Market Scenario

Soft tissue allografts have gained popularity due to technology advancements. Aging population, increase in demand for soft tissue allografts in athletics, rise in number of tissue banks, and surge in number of orthopedic surgical procedures are driving the demand for sterile tissue allografts. Most companies are planning to launch soft tissue allografts products. Rise in awareness is projected to contribute to the growth of the global soft tissue allografts market. Patient awareness has increased significantly, in part due to growth in Internet penetration and easy access to social media. The global soft tissue allografts market is expected to benefit from increased understanding of products and procedures. Furthermore, underlying healthcare trends, growth in importance of sports, and rise in geriatric population are estimated to propel the global market.

Soft Tissue Allografts Market

Soft Tissue Allografts Market Introduction

Soft tissue allografts are used to replace deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. Donor screening, laboratory testing, and tissue preparation are part of the three-stage safety screening process for sterile tissue allografts. Soft tissue allografts are made up of bone, tendons, cartilage, skin, heart valves, and veins; and are used in various surgeries. Soft tissue allograft has been considered a successful procedure for over 150 years, with around 1 million allografts transplanted in the U.S. each year.

Usage of soft tissue allografts has increased across the globe due to the rise in number of orthopedic surgeries and dental implants. Increase in geriatric population, rise in demand for new technological advancements for the production of new tissues by tissue banks, and surge in demand for sterile soft tissue allografts among patients are augmenting the global soft tissue allografts market. Risk of infection and immune response could lead to serious complications such as disruption of infected anastomotic rigid line with a rupture, bowel formation, and microbial infection. Furthermore, high cost of procedures with limited reimbursement is likely to restrain the global soft tissue allografts market.

Request a sample to get extensive insights into the Soft Tissue Allografts Market

Clinical Use in Medical Procedures and Sports Injuries to Drive Global Market

Modern training regimens in athletics, field events, and various other contact sports, such as American football, require athletes to participate in intensive training sessions that are often more strenuous than the sport itself. High-intensity training regimens are directly related to improved athletic performance; however, excessive training causes muscle and bone fatigue and frequently leads to injury.

Sports injury can be caused by an accident, an impact, poor training habits, lack of conditioning, improper equipment, and insufficient warm-up and stretching. Youth injuries are increasing as a result of year-round participation in a single sport. According to the American Academy of Pediatrics, around 30 million children and teenagers participate in organized sports in the U.S. each year, resulting in more than 3.5 million injuries. Sports-related injuries account for one-third of all childhood injuries.

Rise in Orthopedic and Dentistry Cases Associated with Aging to Augment Global Market

Elderly people are more likely to sustain soft tissue injuries. As people get older, they naturally slow down, have less energy, and are less powerful. Hence, they are more vulnerable to injuries. Falls is the leading cause of death among people aged over 65. It is the most common reason for elderly people to visit the emergency room.

Tooth loss is common among the geriatric population and can be caused by disease or trauma. Usage of dental implants to provide support for the replacement of missing teeth has a long and complex history. Research in dental implant designs, materials, and techniques has increased in the past few years. It is expected to rise in the near future due to the growth in the dental implants market and increase in demand for cosmetic dentistry. This is projected to drive the soft tissue allografts market size in the near future.

Increase in Number of Musculoskeletal Reconstructive Procedures Propelling Collagen Allografts Segment

In terms of product type, the collagen allografts segment dominated the global soft tissue allografts market in 2021. The trend is anticipated to continue during the forecast period. Rise in number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Furthermore, increase in usage of collagen allografts in maxillofacial surgery and wound care therapies is expected to drive the segment during the forecast period.

Regional Analysis of Global Soft Tissue Allografts Market

North America dominated the global soft tissue allografts market in 2021. The market in the region is anticipated to grow at the fastest CAGR from 2022 to 2031 due to the presence of key players and high rate of technology adoption. Furthermore, prevalence of diabetic foot ulcers, better diabetes healthcare awareness programs, and increase in number of surgical procedures are augmenting the soft tissue allografts market share of North America.

Development of distribution channels by key players and rise in demand for collagen allografts for the treatment of severe burn injuries and breast reconstruction surgery are the factors driving the soft tissue allografts market in Asia Pacific.

Analysis of Key Players in Global Soft Tissue Allografts Market

The global soft tissue allografts market is fragmented, with the presence of large number of key players. Expansion of product portfolios and mergers & acquisitions are the major strategies adopted by the leading players. Lattice Biologics Ltd., Zimmer Biomet, AlonSource Group, MiMedix Group, AlloSource, CONMED Corporation, Organogenesis, Inc., RTI Surgical, Inc., Osiris Therapeutics, Integra LifeSciences Corporation, Globus Medical, Inc., Straumann Holding AG, Xtant Medical, Alliqua BioMedical, Inc., C. R. Bard, Inc. (Davol, Inc.), B. Braun Melsungen AG, and Arthrex are the soft tissue allografts market key players.

Request a custom report on Soft Tissue Allografts Market

Key Developments in Global Soft Tissue Allografts Market

  • In August 2022, Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the release of CYGNUS Matrix Disks, the newest configuration of the CYGNUS family of amniotic tissue allografts. CYGNUS amniotic tissue allografts are used to cover wounds. They act as soft tissue barriers to help prevent mechanical damage. CYGNUS Matrix Disk is a flexible, multi-layer allograft that preserves the amnion layer, its intermediate/spongy layer, and the chorion layers of the amniotic sac. It also offers better handling and increased workability.
  • In August 2021, AlloSource introduced AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line. The company is the largest allograft provider in the U.S. that develops cutting-edge cellular and tissue products to aid surgeons in healing patients. The thickest dermal graft offered by the company is AlloMend Ultra-Thick ADM, which is available in multiple sizes and has a thickness range of 3.0 mm to 4.0 mm. It is made using cutting-edge processing methods to guarantee that each allograft's thickness is constant throughout the entire graft. The product was created to be used in the replacement or repair of worn-out or insufficient tissue needed for difficult procedures such as superior capsule reconstruction (SCR).

Each of these players has been profiled in the soft tissue allografts market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Global Soft Tissue Allografts Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 3.74 Bn

Market Forecast Value in 2031

More than US$ 6.3 Bn

Growth Rate (CAGR)

5.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Cartilage Allografts
      • Hyaline Cartilage
      • Elastic Cartilage
      • Fibro Cartilage
    • Tendon Allografts
      • Achilles Tendon
      • Tibialis
      • Patellar Tendon
      • Hamstring
    • Meniscus Allografts
    • Dental Allografts
      • Free Gingival Graft
      • Connective Tissue Graft
      • Pedicle Graft
    • Collagen Allografts
    • Amniotic Allografts
  • Application
    • Orthopedic
      • Sports Medicine
      • Spine Surgeries
      • General Orthopedic
      • Reconstruction
    • Dentistry
      • Dental Sensitivity
      • Aesthetics
    • Wound Care
    • Others
  • End-user
    • Hospitals
    • Orthopedic Clinics
    • Dental Clinics
    • Ambulatory Surgical Centers
    • Aesthetic Centers

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Lattice Biologics Ltd.
  • Zimmer Biomet
  • AlonSource Group
  • MiMedix Group
  • AlloSource
  • CONMED Corporation
  • Organogenesis, Inc.
  • RTI Surgical, Inc.
  • Osiris Therapeutics
  • Integra LifeSciences Corporation
  • Globus Medical, Inc.
  • Straumann Holding AG
  • Xtant Medical
  • Alliqua BioMedical, Inc.
  • C. R. Bard, Inc. (Davol, Inc.)
  • B. Braun Melsungen AG
  • Arthrex

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global soft tissue allografts market in 2021?

The global soft tissue allografts market was valued at US$ 3.74 Bn in 2021

How big will be the global soft tissue allografts market in 2031?

The global soft tissue allografts market is projected to reach more than US$ 6.3 Bn by 2031

What will be the CAGR of the global soft tissue allografts market during the forecast period (2022–2031)?

The global soft tissue allografts market is anticipated to grow at a CAGR of 5.5% from 2022 to 2031

What are the prominent trends that affect market growth?

Clinical use in medical procedures & sports injuries and rise in orthopedics & dentistry cases associated with aging

What is the market share of leading segment of the global soft tissue allografts market?

The collagen allografts segment held over 28% share of the global soft tissue allografts market in 2021

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global soft tissue allografts makret during the forecast period.

Who are the prominent players in the global soft tissue allografts market?

Lattice Biologics Ltd., Zimmer Biomet, AlonSource Group, MiMedix Group, AlloSource, CONMED Corporation, Organogenesis, Inc., RTI Surgical, Inc., Osiris Therapeutics, Integra LifeSciences Corporation, Globus Medical, Inc., Straumann Holding AG, Xtant Medical, Alliqua BioMedical, Inc., C. R. Bard, Inc. (Davol, Inc.), B. Braun Melsungen AG, and Arthrex

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Soft Tissue Allografts Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Soft Tissue Allografts Market Analysis and Forecasts, 2017–2031

    5. Key Insights

        5.1. Key Mergers & Acquisitions

        5.2. Technological Advancements

        5.3. COVID-19 Impact Analysis

    6. Global Soft Tissue Allografts Market Analysis and Forecast, By Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Cartilage Allografts

                6.3.1.1. Hyaline Cartilage

                6.3.1.2. Elastic Cartilage

                6.3.1.3. Fibro Cartilage

            6.3.2. Tendon Allografts

                6.3.2.1. Achilles Tendon

                6.3.2.2. Tibialis

                6.3.2.3. Patellar Tendon

                6.3.2.4. Hamstring

            6.3.3. Dental Allografts

                6.3.3.1. Free Gingival Graft

                6.3.3.2. Connective Tissue Graft

                6.3.3.3. Pedicle Graft

            6.3.4. Meniscus Allografts

            6.3.5. Collagen Allografts

            6.3.6. Amniotic Allografts

        6.4. Market Attractiveness Analysis, By Product

    7. Global Soft Tissue Allografts Market Analysis and Forecast, By Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Orthopedics

                7.3.1.1. Sports Medicine

                7.3.1.2. Spine Surgeries

                7.3.1.3. General Orthopedics

                7.3.1.4. Reconstruction

            7.3.2. Dentistry

                7.3.2.1. Dental Sensitivity

                7.3.2.2. Aesthetics

            7.3.3. Wound Care

            7.3.4. Others

        7.4. Market Attractiveness Analysis, By Application

    8. Global Soft Tissue Allografts Market Analysis and Forecast, By End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Orthopedic Clinics

            8.3.2. Dental Clinics

            8.3.3. Ambulatory Surgical Centers

            8.3.4. Aesthetic Centers

        8.4. Market Attractiveness Analysis, By End-user

    9. Global Soft Tissue Allografts Market Analysis and Forecast, By Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, By Region

    10. North America Soft Tissue Allografts Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Cartilage Allografts

                10.2.1.1. Hyaline Cartilage

                10.2.1.2. Elastic Cartilage

                10.2.1.3. Fibro Cartilage

            10.2.2. Tendon Allografts

                10.2.2.1. Achilles Tendon

                10.2.2.2. Tibialis

                10.2.2.3. Patellar Tendon

                10.2.2.4. Hamstring

            10.2.3. Dental Allografts

                10.2.3.1. Free Gingival Graft

                10.2.3.2. Connective Tissue Graft

                10.2.3.3. Pedicle Graft

            10.2.4. Meniscus Allografts

            10.2.5. Collagen Allografts

            10.2.6. Amniotic Allografts

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Orthopedics

                10.3.1.1. Sports Medicine

                10.3.1.2. Spine Surgeries

                10.3.1.3. General Orthopedics

                10.3.1.4. Reconstruction

            10.3.2. Dentistry

                10.3.2.1. Dental Sensitivity

                10.3.2.2. Aesthetics

            10.3.3. Wound Care

            10.3.4. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Orthopedic Clinics

            10.4.2. Dental Clinics

            10.4.3. Ambulatory Surgical Centers

            10.4.4. Aesthetic Centers

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Soft Tissue Allografts Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Cartilage Allografts

                11.2.1.1. Hyaline Cartilage

                11.2.1.2. Elastic Cartilage

                11.2.1.3. Fibro Cartilage

            11.2.2. Tendon Allografts

                11.2.2.1. Achilles Tendon

                11.2.2.2. Tibialis

                11.2.2.3. Patellar Tendon

                11.2.2.4. Hamstring

            11.2.3. Dental Allografts

                11.2.3.1. Free Gingival Graft

                11.2.3.2. Connective Tissue Graft

                11.2.3.3. Pedicle Graft

            11.2.4. Meniscus Allografts

            11.2.5. Collagen Allografts

            11.2.6. Amniotic Allografts

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Orthopedics

                11.3.1.1. Sports Medicine

                11.3.1.2. Spine Surgeries

                11.3.1.3. General Orthopedics

                11.3.1.4. Reconstruction

            11.3.2. Dentistry

                11.3.2.1. Dental Sensitivity

                11.3.2.2. Aesthetics

            11.3.3. Wound Care

            11.3.4. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Orthopedic Clinics

            11.4.2. Dental Clinics

            11.4.3. Ambulatory Surgical Centers

            11.4.4. Aesthetic Centers

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Soft Tissue Allografts Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Cartilage Allografts

                12.2.1.1. Hyaline Cartilage

                12.2.1.2. Elastic Cartilage

                12.2.1.3. Fibro Cartilage

            12.2.2. Tendon Allografts

                12.2.2.1. Achilles Tendon

                12.2.2.2. Tibialis

                12.2.2.3. Patellar Tendon

                12.2.2.4. Hamstring

            12.2.3. Dental Allografts

                12.2.3.1. Free Gingival Graft

                12.2.3.2. Connective Tissue Graft

                12.2.3.3. Pedicle Graft

            12.2.4. Meniscus Allografts

            12.2.5. Collagen Allografts

            12.2.6. Amniotic Allografts

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Orthopedics

                12.3.1.1. Sports Medicine

                12.3.1.2. Spine Surgeries

                12.3.1.3. General Orthopedics

                12.3.1.4. Reconstruction

            12.3.2. Dentistry

                12.3.2.1. Dental Sensitivity

                12.3.2.2. Aesthetics

            12.3.3. Wound Care

            12.3.4. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Orthopedic Clinics

            12.4.2. Dental Clinics

            12.4.3. Ambulatory Surgical Centers

            12.4.4. Aesthetic Centers

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Soft Tissue Allografts Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Cartilage Allografts

                13.2.1.1. Hyaline Cartilage

                13.2.1.2. Elastic Cartilage

                13.2.1.3. Fibro Cartilage

            13.2.2. Tendon Allografts

                13.2.2.1. Achilles Tendon

                13.2.2.2. Tibialis

                13.2.2.3. Patellar Tendon

                13.2.2.4. Hamstring

            13.2.3. Dental Allografts

                13.2.3.1. Free Gingival Graft

                13.2.3.2. Connective Tissue Graft

                13.2.3.3. Pedicle Graft

            13.2.4. Meniscus Allografts

            13.2.5. Collagen Allografts

            13.2.6. Amniotic Allografts

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Orthopedics

                13.3.1.1. Sports Medicine

                13.3.1.2. Spine Surgeries

                13.3.1.3. General Orthopedics

                13.3.1.4. Reconstruction

            13.3.2. Dentistry

                13.3.2.1. Dental Sensitivity

                13.3.2.2. Aesthetics

            13.3.3. Wound Care

            13.3.4. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Orthopedic Clinics

            13.4.2. Dental Clinics

            13.4.3. Ambulatory Surgical Centers

            13.4.4. Aesthetic Centers

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Soft Tissue Allografts Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Cartilage Allografts

                14.2.1.1. Hyaline Cartilage

                14.2.1.2. Elastic Cartilage

                14.2.1.3. Fibro Cartilage

            14.2.2. Tendon Allografts

                14.2.2.1. Achilles Tendon

                14.2.2.2. Tibialis

                14.2.2.3. Patellar Tendon

                14.2.2.4. Hamstring

            14.2.3. Dental Allografts

                14.2.3.1. Free Gingival Graft

                14.2.3.2. Connective Tissue Graft

                14.2.3.3. Pedicle Graft

            14.2.4. Meniscus Allografts

            14.2.5. Collagen Allografts

            14.2.6. Amniotic Allografts

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Orthopedics

                14.3.1.1. Sports Medicine

                14.3.1.2. Spine Surgeries

                14.3.1.3. General Orthopedic

                14.3.1.4. Reconstruction

            14.3.2. Dentistry

                14.3.2.1. Dental Sensitivity

                14.3.2.2. Aesthetics

            14.3.3. Wound Care

            14.3.4. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Orthopedic Clinics

            14.4.2. Dental Clinics

            14.4.3. Ambulatory Surgical Centers

            14.4.4. Aesthetic Centers

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. Lattice Biologics Ltd

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Zimmer Biomet

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. AlonSource Group

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. MiMedix Group.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. AlloSource.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. CONMED Corporation.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. Organogenesis, Inc.

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. RTI Surgical, Inc.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. Osiris Therapeutics.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

            15.3.10. Integra LifeSciences Corporation.

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Strategic Overview

            15.3.11. Globus Medical, Inc.

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Strategic Overview

            15.3.12. B. Braun Melsungen AG.

                15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Strategic Overview

            15.3.13. Arthrex

                15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Strategic Overview

    List of Tables

    Table 01: Global Soft Tissue Allografts Market Pipeline Analysis

    Table 02: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 03: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 04: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Region, 2022–2031

    Table 05: North America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country, 2022–2031

    Table 06: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 07: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 08: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022–2031

    Table 09: Europe Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

    Table 10: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 11: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 12: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user,2022–2031

    Table 13: Asia Pacific Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

    Table 14: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 15: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 16: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022–2031

    Table 17: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

    Table 18: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 19: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 20: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022–2031

    Table 21: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

    Table 22: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

    Table 23: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

    Table 24: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022–2031

    List of Figures

    Figure 01: Global Soft Tissue Allografts Market (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

    Figure 03: Global Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 04: Global Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 05: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Product Type, 2017–2031

    Figure 06: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Application, 2017–2031

    Figure 07: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2017–2031

    Figure 08: North America Soft Tissue Allografts Market (US$ Mn) Forecast, 2017–2031

    Figure 09: North America Soft Tissue Allografts Market Share Analysis, by Country, 2021 and 2031

    Figure 10: North America Soft Tissue Allografts Market Attractiveness Analysis, by Country, 2022–2031

    Figure 11: North America Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031

    Figure 12: North America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 13: North America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 14: North America Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 15: North America Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 16: North America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 17: Europe Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

    Figure 18: Europe Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 19: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 20: Europe Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031

    Figure 21: Europe Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 22: Europe Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 23: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 24: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 25: Europe Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 26: Asia Pacific Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

    Figure 27: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 28: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 29: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

    Figure 30: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 31: Asia Pacific Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 32: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 33: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 34: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 35: Latin America Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

    Figure 36: Latin America Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 37: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 38: Latin America Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

    Figure 39: Latin America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 40: Latin America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 41: Latin America Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 42: Latin America Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 43: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 44: Middle East & Africa Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

    Figure 45: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 46: Middle East & Africa Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 46: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

    Figure 47: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

    Figure 48: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

    Figure 49: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 50: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 51: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved